PRPH's logo.
Ticker Symbol: PRPH

ProPhase Labs Inc

$6.12 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0000868278

Company Profile

ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The Company is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States. This includes the development and marketing of dietary supplements under the TK Supplements® brand. The Company is also developing ProPhase Diagnostics, Inc. ("ProPhase Diagnostics") to offer COVID-19 and other Respiratory Pathogen Panel (RPP) Molecular tests. The Company also continues to actively pursue strategic investments and acquisition opportunities for other companies, technologies and products.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
CEO: N/A
Tags:
  • Consumer Non-Durables
  • Household/Personal Care
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 3, 2023 03:30 PM EST
Previous Close: $4.36
Change: -$0.02 ( -0.46%)
Days Range: $4.36 - $4.62
Beta: 0.34
52wk. High: $12.69
52wk. Low: $4.05
Ytd. Change -54.97%
50 Day Moving Average: $4.43
200 Day Moving Average: $6.72
Shares Outstanding: 16845029

Valuation

Market Cap: 7.3B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A